Week4, 2021
1. Influenza activity remains unusually low, with only 0.1% of respiratory specimens testing positive for influenza in clinical labs.
2. Public health labs reported three positive specimens, with 66.7% being Influenza A and 33.3% Influenza B.
3. Outpatient visits for influenza-like illness (ILI) accounted for 1.1%, a decrease from 1.3% in the previous week, and remain below the national baseline of 2.6%.
4. Cumulative hospitalizations for laboratory-confirmed influenza stand at a rate of 0.5 per 100,000, significantly lower than average for this time of year.
5. Pneumonia, influenza, or COVID-19 (PIC) accounted for 28.4% of deaths, well above the epidemic threshold of 7.1%, primarily driven by COVID-19.
6. No new pediatric influenza-associated deaths were reported; the total remains one for the 2020-21 season.
7. Influenza A accounted for 28% of clinical lab positives, while Influenza B made up 72%, emphasizing a higher prevalence of Influenza B.
8. Minimal activity was reported across all jurisdictions, while ILI surveillance and healthcare-seeking patterns were affected by the COVID-19 pandemic.
9. The CDC advises prompt vaccination, though no notable trends in vaccine uptake were observed.
10. Influenza trends remain uncertain, with potential impacts from evolving healthcare behaviors linked to the ongoing COVID-19 pandemic.